1712 related articles for article (PubMed ID: 27807831)
1. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
2. Quantitative imaging in cancer evolution and ecology.
Gatenby RA; Grove O; Gillies RJ
Radiology; 2013 Oct; 269(1):8-15. PubMed ID: 24062559
[TBL] [Abstract][Full Text] [Related]
3. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
[TBL] [Abstract][Full Text] [Related]
4. Pathology to enhance precision medicine in oncology: lessons from landscape ecology.
Lloyd MC; Rejniak KA; Brown JS; Gatenby RA; Minor ES; Bui MM
Adv Anat Pathol; 2015 Jul; 22(4):267-72. PubMed ID: 26050264
[TBL] [Abstract][Full Text] [Related]
5. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces.
Lloyd MC; Cunningham JJ; Bui MM; Gillies RJ; Brown JS; Gatenby RA
Cancer Res; 2016 Jun; 76(11):3136-44. PubMed ID: 27009166
[TBL] [Abstract][Full Text] [Related]
6. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
7. Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.
Valous NA; Lahrmann B; Halama N; Bergmann F; Jäger D; Grabe N
Med Phys; 2016 Jun; 43(6):2936-2947. PubMed ID: 27277043
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
[TBL] [Abstract][Full Text] [Related]
9. Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.
Reinartz R; Wang S; Kebir S; Silver DJ; Wieland A; Zheng T; Küpper M; Rauschenbach L; Fimmers R; Shepherd TM; Trageser D; Till A; Schäfer N; Glas M; Hillmer AM; Cichon S; Smith AA; Pietsch T; Liu Y; Reynolds BA; Yachnis A; Pincus DW; Simon M; Brüstle O; Steindler DA; Scheffler B
Clin Cancer Res; 2017 Jan; 23(2):562-574. PubMed ID: 27521447
[TBL] [Abstract][Full Text] [Related]
10. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.
Meyer M; Reimand J; Lan X; Head R; Zhu X; Kushida M; Bayani J; Pressey JC; Lionel AC; Clarke ID; Cusimano M; Squire JA; Scherer SW; Bernstein M; Woodin MA; Bader GD; Dirks PB
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):851-6. PubMed ID: 25561528
[TBL] [Abstract][Full Text] [Related]
11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
12. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.
Stringfield O; Arrington JA; Johnston SK; Rognin NG; Peeri NC; Balagurunathan Y; Jackson PR; Clark-Swanson KR; Swanson KR; Egan KM; Gatenby RA; Raghunand N
Tomography; 2019 Mar; 5(1):135-144. PubMed ID: 30854451
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
[TBL] [Abstract][Full Text] [Related]
17. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
18. Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI.
Schuenke P; Paech D; Koehler C; Windschuh J; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Zaiss M
Sci Rep; 2017 Feb; 7():42093. PubMed ID: 28169369
[TBL] [Abstract][Full Text] [Related]
19. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Ferl GZ; Ng CM
Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
